Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI
Open Access
- 23 June 2010
- journal article
- Published by Springer Science and Business Media LLC in Retrovirology
- Vol. 7 (1), 55
- https://doi.org/10.1186/1742-4690-7-55
Abstract
Background HIV-1 is usually transmitted in the presence of semen. We have shown that semen boosts HIV-1 infection and contains fragments of prostatic acid phosphatase (PAP) forming amyloid aggregates termed SEVI (semen-derived enhancer of viral infection) that promote virion attachment to target cells. Despite its importance for the global spread of HIV-1, however, the effect of semen on virus infection is controversial. Results Here, we established methods allowing the meaningful analysis of semen by minimizing its cytotoxic effects and partly recapitulating the conditions encountered during sexual HIV-1 transmission. We show that semen rapidly and effectively enhances the infectivity of HIV-1, HIV-2, and SIV. This enhancement occurs independently of the viral genotype and coreceptor tropism as well as the virus producer and target cell type. Semen-mediated enhancement of HIV-1 infection was also observed under acidic pH conditions and in the presence of vaginal fluid. We further show that the potency of semen in boosting HIV-1 infection is donor dependent and correlates with the levels of SEVI. Conclusions Our results show that semen strongly enhances the infectivity of HIV-1 and other primate lentiviruses and that SEVI contributes to this effect. Thus, SEVI may play an important role in the sexual transmission of HIV-1 and addition of SEVI inhibitors to microbicides may improve their efficacy.Keywords
This publication has 52 references indexed in Scilit:
- The Origins of Sexually Transmitted HIV Among Men Who Have Sex with MenScience Translational Medicine, 2010
- HIV infection of the male genital tract – consequences for sexual transmission and reproductionInternational Journal of Andrology, 2010
- Aminoquinoline Surfen Inhibits the Action of SEVI (Semen-derived Enhancer of Viral Infection)Online Journal of Public Health Informatics, 2010
- NMR Structure in a Membrane Environment Reveals Putative Amyloidogenic Regions of the SEVI Precursor Peptide PAP248−286Journal of the American Chemical Society, 2009
- Helical Conformation of the SEVI Precursor Peptide PAP248-286, a Dramatic Enhancer of HIV Infectivity, Promotes Lipid Aggregation and FusionBiophysical Journal, 2009
- Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cellsThe Journal of Experimental Medicine, 2009
- Cationic polypeptides contribute to the anti‐HIV‐1 activity of human seminal plasmaThe FASEB Journal, 2009
- The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infectionProceedings of the National Academy of Sciences of the United States of America, 2009
- Surfen, a small molecule antagonist of heparan sulfateProceedings of the National Academy of Sciences of the United States of America, 2008
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionProceedings of the National Academy of Sciences of the United States of America, 2008